Omega Healthcare (OHI) Q4 2025 earnings review
Record Investment Volume Meets Record Low Leverage
Omega Healthcare closed 2025 with a show of force, delivering $0.80 in Adjusted FFO (AFFO) per share—an 8% YoY increase. The company deployed over $1.1 billion in capital for the year while simultaneously reducing leverage to its lowest level in history through aggressive debt repayment ($1.27 billion in Q4 alone). While the Genesis bankruptcy remains a headline risk, the operator continues to pay full rent. Management issued initial 2026 AFFO guidance of $3.15-$3.25, implying stable but decelerating growth (+3% at midpoint) compared to the breakout 2025 performance.
🐂 Bull Case
Omega repaid $1.27 billion in debt during Q4, including high-cost senior notes and term loans. The company exited 2025 with leverage at historic lows, providing massive dry powder for future acquisitions without immediate need for expensive financing.
The company deployed $1.1 billion in FY25, including a massive $334 million in Q4 alone. The new Saber JV (49% stake) and OpCo investment signal a pivot toward higher-yield structures, moving beyond plain vanilla triple-net leases to drive returns.
🐻 Bear Case
Omega is increasingly moving into operational risks. The new $93M investment in Saber's Operating Company (OpCo) and the RIDEA structures mean Omega is now more exposed to labor costs and reimbursement rate volatility than it was under a pure triple-net model.
While Genesis paid its $13M Q4 rent, the operator is still in Chapter 11. Bankruptcy proceedings are unpredictable; a lease rejection or renegotiation remains a tail risk that could impact ~5% of revenues.
⚖️ Verdict: 🟢
Bullish. Omega has pulled off a difficult feat: aggressive external growth ($1.1B deployed) while significantly de-risking the balance sheet. The dividend is well-covered (88% payout ratio based on FAD), and the Genesis risk appears contained.
Key Themes
The Saber Pivot: Moving into Operations
Omega formed a major Joint Venture with Saber Healthcare, investing $222M for a 49% stake in the PropCo (64 facilities) and $93M for a 9.9% stake in the OpCo. This creates a vertical alignment but introduces operational exposure. The deal contributed to Q4 numbers and is a primary driver for 2026 growth, signaling a strategic shift to capture upside beyond fixed rent.
Maplewood Recovery Continues
Maplewood, a key tenant that previously struggled, is stabilizing. Rent payments increased to $18.9M in Q4 vs $18.7M in Q3. While still not at the original contractual full potential, the consistent sequential growth proves the turnaround thesis is working and supports the dividend coverage.
Tenant Concentration & Credit Watch
Genesis (Chapter 11) and Maplewood (cash basis) represent significant revenue concentration. While metrics are improving (Operator coverage ex-Genesis/Maplewood is healthy), the reliance on distressed or restructuring tenants to hit guidance targets leaves little margin for error.
Capital Recycling Efficiency
Omega successfully sold 4 facilities in Q4 for $18.7M (booking a $6.1M gain) and repaid $1.27B in debt. This active capital recycling has kept the portfolio fresh and leverage low despite the heavy acquisition volume. The termination of the $1.25B ATM for a new $2.0B program suggests they intend to keep issuing equity to fund growth.
Other KPIs
Accelerating. Up 17% YoY (vs $214M in 24Q4). On a per-share basis, growth was 8% ($0.80 vs $0.74), demonstrating that capital deployment is outpacing the dilution from share issuances (share count rose from 287M to 313M).
Stable/Accelerating. FAD covers the dividend ($0.76/share vs $0.67 dividend). This implies an 88% payout ratio, providing a comfortable safety cushion that was absent in prior years when coverage was tight.
Management repaid $600M in notes and $429M in term loans in Q4 alone. While exact Net Debt/EBITDA wasn't explicitly tabled in the summary, the narrative confirms leverage is at a historic low, reducing interest rate sensitivity.
Guidance
Decelerating. The midpoint of $3.20 implies 3.2% growth over 2025's $3.10. While positive, this is a slowdown from the 8% growth seen in 2025 (FY24 was $2.87). The guidance assumes Genesis continues paying full rent and Maplewood payments step up slightly to $6.5M/month in Feb 2026.
Key Questions
Saber OpCo Risk Profile
The $93M investment in Saber's OpCo is a departure from the traditional landlord model. How are you hedging against wage inflation or reimbursement cuts that directly impact OpCo margins, unlike triple-net leases?
Genesis Bankruptcy Exit
Genesis is paying rent, but they are still in Chapter 11. What is the timeline for their exit, and is there any risk of a 'force majeure' renegotiation of the master lease terms before they emerge?
Maplewood Ceiling
Maplewood payments are increasing, but when do you project they will cover the full contractual rent inclusive of the deferred balances? Is the $6.5M/month run rate the new permanent baseline?